Logo

MDxHealth's SelectMDx Liquid Biopsy Test for Prostate Cancer

Oct 14, 2015

MDxHealth, in conjunction with DDL Diagnostic Laboratory, has launched SelectMDx patient testing in the Netherlands, with plans to expand the offering to other European countries in early 2016. The test is made up of novel biomarkers discovered by Jack Schalakan and uses a non-invasive "liquid biopsy" method to identify patients at low risk for prostate cancer using urine samples. In clinical studies, SelectMDx has been shown to outperform PCA3, improving the information available to urologists seeking to further reduce unnecessary invasive biopsy procedures, said MDxHealth in a statement.

Breaking News
The Scan

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.

Culture-Based Methods, Shotgun Sequencing Reveal Transmission of Bifidobacterium Strains From Mothers to Infants

In a Nature Communications study, culture-based approaches along with shotgun sequencing give a better picture of the microbial strains transmitted from mothers to infants.

Microbial Communities Can Help Trees Adapt to Changing Climates

Tree seedlings that were inoculated with microbes from dry, warm, or cold sites could better survive drought, heat, and cold stress, according to a study in Science.

A Combination of Genetics and Environment Causes Cleft Lip

In a study published in Nature Communications, researchers investigate what combination of genetic and environmental factors come into play to cause cleft lip/palate.